TENX
Tenax Therapeutics Inc
NASDAQ: TENX · HEALTHCARE · BIOTECHNOLOGY
$13.11
+2.58% today
Updated 2026-04-30
Market cap
$376.32M
P/E ratio
—
P/S ratio
414.72x
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$5 – $18
Volume
0.5M
Tenax Therapeutics Inc (TENX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $1.26M | $610788.00 | $2.00M | $8.39M | $5.03M | $3.53M | $5.89M | $33.94M | $93.43M | $93.43M | $72.99M | $23.34M | $9.89M | $13.34M | $6.37M | $6.87M | $5.99M | $3.40M | $11.68M | $96.69M |
| Cash & equivalents | $588763.00 | $382.00 | $940239.00 | $4.15M | $2.88M | $632706.00 | $3.28M | $6.34M | $58.32M | $58.32M | $3.66M | $10.00M | $1.60M | $12.37M | $4.91M | $6.25M | $5.58M | $2.12M | $9.79M | $94.85M |
| Current assets | $666449.00 | $154607.00 | $1.19M | $4.28M | $3.64M | $2.18M | $4.33M | $7.39M | $58.97M | $58.97M | $20.56M | $13.63M | $8.06M | $13.32M | $6.18M | $6.80M | $5.69M | $3.21M | $11.68M | $96.69M |
| Total liabilities | $313944.00 | $424572.00 | $2.46M | $1.79M | $1.20M | $1.40M | $6.76M | $3.64M | $10.54M | $10.54M | $12.56M | $6.20M | $1.01M | $1.57M | $2.59M | $2.24M | $1.75M | $1.91M | $3.59M | $4.69M |
| Current liabilities | $313944.00 | $424572.00 | $2.42M | $600409.00 | $1.20M | $1.40M | $5.81M | $3.61M | $2.57M | $2.57M | $4.60M | $6.20M | $1.01M | $1.57M | $2.53M | $2.12M | $1.56M | $1.85M | $3.59M | $4.69M |
| Long-term debt | — | — | $540000.00 | $228000.00 | $3000.00 | $4.46M | $1.36M | $2.99M | $0.00 | $0.00 | — | $0.00 | $0.00 | — | — | $124166.00 | — | — | — | — |
| Shareholder equity | $948401.00 | $186216.00 | $-458247.00 | $6.60M | $3.83M | $2.13M | $-871464.00 | $30.30M | $82.89M | $82.89M | $60.42M | $17.14M | $8.88M | $11.77M | $3.77M | $4.63M | $4.24M | $1.49M | $8.10M | $91.99M |
| Retained earnings | $-23.62M | $-27.69M | $-35.30M | $-54.26M | $-78.70M | $-81.47M | $-105.01M | $-126.17M | $-136.59M | $-136.59M | $-160.74M | $-204.66M | $-213.50M | $-227.80M | $-236.17M | $-246.02M | $-278.49M | $-289.54M | $-297.25M | $-314.86M |
| Accounts receivable | — | — | — | $32286.00 | $158667.00 | $138867.00 | $166553.00 | $166290.00 | $66108.00 | $66108.00 | $49448.00 | $72599.00 | $50171.00 | $0.00 | — | — | — | — | — | — |
| Inventory | — | — | — | $-32286.00 | $409945.00 | $535090.00 | $116707.00 | $97437.00 | $0.00 | $401964.00 | $164334.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | $0.00 | $3.30M | $11.27M | $11.27M | $11.27M | $0.00 | $0.00 | — | — | — | — | — | — | — |